carcinoma

(redirected from hepatocarcinoma)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to hepatocarcinoma: hepatocellular carcinoma

carcinoma:

see neoplasmneoplasm
or tumor,
tissue composed of cells that grow in an abnormal way. Normal tissue is growth-limited, i.e., cell reproduction is equal to cell death. Feedback controls limit cell division after a certain number of cells have developed, allowing for tissue repair
..... Click the link for more information.
.
The Columbia Electronic Encyclopedia™ Copyright © 2013, Columbia University Press. Licensed from Columbia University Press. All rights reserved. www.cc.columbia.edu/cu/cup/

carcinoma

[‚kärs·ən′ō·mə]
(medicine)
A malignant epithelial tumor.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.

carcinoma

Pathol
1. any malignant tumour derived from epithelial tissue
2. another name for cancer
Collins Discovery Encyclopedia, 1st edition © HarperCollins Publishers 2005
References in periodicals archive ?
The AKT inhibitor MK-2206 is cytotoxic in hepatocarcinoma cells displaying hyperphosphorylated AKT-1 and synergizes with conventional chemotherapy.
Wang, "Nm23-H1 suppresses hepatocarcinoma cell adhesion and migration on fibronectin by modulating glycosylation of integrin beta1," Journal of Experimental & Clinical Cancer Research, vol.
Caption: Figure 2: Quantitation of hepatic genes: AFP, A1AT, HNF4a, albumin mRNA levels by RT-qPCR analysis in HLCs, HepG2 (hepatocarcinoma cell line), hepatocytes, and iPSCs.
A comparison of the prognosis of patients with fibrolamellar carcinoma to that of patients with hepatocarcinoma shows improved survival (RR 2.02 95% CI 1.38 - 3.16) [33].
Also, ANXA3 expression was upregulated by 2.3 times in hepatocarcinoma cell lines Hca-F with high metastatic potential as compared to hepatocarcinoma cell lines Hca-P with low metastatic potential, indicating its involvement in hepatocarcinoma metastasis [13].
Moreover, the reverse correlation between ROS generation and reduction of glutathione (GSH) in human hepatocellular carcinoma cell line (SMMC-7721), rat hepatocarcinoma cell line (CBRH-7919), human liver cell line (HL-7702), and rat liver cell line (BRL-3A) has shown the toxicity of Ti[O.sub.2] NPs [13].
In some patients, NAFLD can progress to cirrhosis and further to hepatocarcinoma. NAFLD patients belonging to one subgroup have liver cell injury and inflammation, in addition to excessive fat (steatohepatitis).
Tonetti, "Effects of microRNAs on fucosyltransferase 8 (FUT8) expression in hepatocarcinoma cells," PLOS ONE, vol.

Full browser ?